Institutional Ownership
Gt Biopharma Inc
CUSIP 36254L308COMGTBPQ1 2026
Institutional Holders
39
13F filers
Shares Held
914.6K
Aggregate institutional
Institutional Value
$353.7K
Q1 2026
Net New Holders
+2
12 new · 10 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions12
Increased7
Decreased5
Sold out10
Institutional Holders
39 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Geode Capital Management, LLC | 294.5K | $120.2K | +275.2K | Added |
| 2 | Arax Advisory Partners | 93.6K | $38.2K | +93.6K | New |
| 3 | Citadel Advisors LLC | 66.2K | $27.0K | −14.6K | Reduced |
| 4 | Seacrest Wealth Management, LLC | 50.0K | $20.4K | 0 | Held |
| 5 | Ubs Group AG | 46.0K | $18.8K | +46.0K | Added |
| 6 | Two Sigma Securities, LLC | 31.8K | $13.0K | +19.3K | Added |
| 7 | Lpl Financial LLC | 30.4K | $12.4K | +19.8K | Added |
| 8 | Invst, LLC | 23.4K | $9.6K | +23.4K | New |
| 9 | Osaic Holdings, Inc. | 21.0K | $8.6K | +19.0K | Added |
| 10 | Cerity Partners LLC | 20.0K | $8.2K | +5.0K | Added |
29 more institutional holders on Premium
See every fund holding Gt Biopharma Inc, with full quarter-over-quarter share changes.
Unlock all holders